Jump to content

Search the Community

Showing results for tags 'immunesystem'.

  • Search By Tags

    Type tags separated by commas.
  • Search By Author

Content Type


Forums

  • Welcome Center
    • Getting Started
    • New From Neuronline!
    • Community Leaders Posts
  • Virtual Events
    • Extended Discussion
    • Event Recaps
    • Live Chats
  • Scientific Research and Training
    • Scientific Research Discussion
    • Foundations of Rigorous Neuroscience
    • Optogenetics Training Series
    • Program Development
  • Career Discussions
    • Professional Development
    • Career Advice
    • Career Paths
    • Career Stage
  • Diversity
    • Diversity Discussion
    • International Experiences
  • Outreach and Advocacy
    • Outreach and Advocacy Discussion
    • Brain Awareness & Teaching
    • Animals in Research
  • Support
  • Latin American Training Program's Webinars
  • Latin American Training Program's Opportunities
  • Latin American Training Program's Annual Meeting
  • Latin American Training Program's General Discussion
  • Latin American Training Program's Resources
  • Latin American Training Program's SfN Global Connectome 2021
  • Latin American Training Program's Live Chats
  • SfN Chapters's Topics

Calendars

  • Community Calendar
  • NSP
  • Latin American Training Program's Events
  • SfN Chapters's Events

Product Groups

There are no results to display.


Find results in...

Find results that contain...


Date Created

  • Start

    End


Last Updated

  • Start

    End


Filter by number of...

Found 1 result

  1. Researchers at Columbia University and The La Jolla Institute for Allergy and Immunology have evidence that an autoimmune response may play a role the development of Parkinson’s Disease (PD.) Researchers have long suspected that the immune system played a role in PD, but these “findings show that two fragments of alpha-synuclein, a protein that accumulates in the brain cells of people with Parkinson’s, can activate the T cells involved in autoimmune attacks,” according to David Sulzer of Columbia. “It remains to be seen whether the immune response to alpha-synuclein is an initial cause of Parkinson’s or if it contributes to neuronal death and worsening symptoms after the onset of the disease,” says Alessandro Sette of La Jolla. This finding may lead to a therapies involving the immune response to alpha-synuclein. The research was published in Nature.
×
×
  • Create New...